In a letter to New York State Senator James Seward, the Federal Trade Commission warns a New York Assembly bill that regulates health plan use of mail order pharmacies would would likely raise prescription prices and reduce access to affordable drugs.
According to the FTC, Assembly Bill 5502-B would limit a health plan's ability to offer favorable treatment to a low cost mail order pharmacy and would undercut pharmacies' incentives to bid aggressively for a health plan's business. This would likely raise prices for health plan prescription drugs and those cost increases could be passed on to patients.
In some cases, the FTC argues, plans may respond to higher costs by reducing the scope of prescription drug coverage, or by eliminating prescription drug coverage entirely.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
